Apply the EUCAST breakpoints of Vibrio to the species that EUCAST states only

The Vibrio sheet (v12.0 to v16.1) states: "Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus." The rows of the genus are therefore replaced by rows of these species, with the statement in the note. Other species and isolates identified at genus level give NA, or use PK/PD breakpoints in EUCAST 2022-2023. CLSI is unchanged.

Any other wording of "breakpoints are valid for" now stops the script, so that a new statement cannot be missed.
This commit is contained in:
dr. M.S. (Matthijs) Berends committed 2026-11-03 17:14:15 +01:00
1 parent 81f5aaa7b8
commit 361dfc28f7
14 files changed
+550 -113

No files matched your search

Binary file not shown.
Binary file not shown.
Binary file not shown.
Binary file not shown.
Binary file not shown.
+490 -108
View File
@@ -2962,38 +2962,114 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
"EUCAST 2026" "human" "human" "MIC" "B_THMSC_RAMS" 2 "SAM" "Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[1] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents. | [2] For susceptibility testing purposes, the concentration of sulbactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_THMSC_RAMS" 2 "TZP" "Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 28 28 FALSE FALSE "[A] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents."
"EUCAST 2026" "human" "human" "MIC" "B_THMSC_RAMS" 2 "TZP" "Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[1] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents. | [4] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 21 21 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "AZM" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "CIP" "ECOFF" 0.008 0.008 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "DOX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "ERY" "ECOFF" 16 16 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "LVX" "ECOFF" 0.016 0.016 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "MEM" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "SXT" "ECOFF" 0.125 0.125 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "TCY" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "TZP" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2026" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2026" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2026" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 16.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "CIP" "ECOFF" 0.125 0.125 FALSE FALSE
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "CTX" "ECOFF" 0.25 0.25 FALSE FALSE
"EUCAST 2026" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "TCY" "ECOFF" 4 4 FALSE FALSE
@@ -6035,38 +6111,114 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
"EUCAST 2025" "human" "human" "DISK" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 15 15 FALSE FALSE "[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2025" "human" "human" "MIC" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 15.0)" 2 2 FALSE FALSE "[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_STTZR_STTZ" 2 "TZP" "ECOFF" 4 4 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 21 21 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "AZM" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "CIP" "ECOFF" 0.008 0.008 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "DOX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "ERY" "ECOFF" 16 16 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "LVX" "ECOFF" 0.016 0.016 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "MEM" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "SXT" "ECOFF" 0.125 0.125 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "TCY" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_VIBRI_CHLR" 2 "TZP" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2025" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2025" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2025" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 15.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "CIP" "ECOFF" 0.125 0.125 FALSE FALSE
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "CTX" "ECOFF" 0.25 0.25 FALSE FALSE
"EUCAST 2025" "ECOFF" "ECOFF" "MIC" "B_YERSN_ENTR" 2 "TCY" "ECOFF" 4 4 FALSE FALSE
@@ -7978,28 +8130,104 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
"EUCAST 2024" "human" "human" "MIC" "B_STRPT_VIRI" 2.5 "TEC" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)" 2 2 FALSE FALSE "[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2024" "human" "human" "DISK" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 15 15 FALSE FALSE "[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2024" "human" "human" "MIC" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)" 2 2 FALSE FALSE "[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 21 21 FALSE FALSE
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2024" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2024" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2024" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 14.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2024" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2024" "human" "human" "MIC" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2024" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4 "IPM" "Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)" "10 mcg" 50 19 FALSE FALSE "[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
@@ -10008,28 +10236,105 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2023" "human" "human" "MIC" "B_STRPT_VIRI" 2.6 "TZP" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)" FALSE FALSE "[No breakpoint] EUCAST gives Note (see note) | [1] Benzylpenicillin (MIC or disk diffusion) can be used to screen for beta-lactam resistance in viridans group streptococci. Isolates categorised as screen negative can be reported susceptible to beta-lactam agents for which clinical breakpoints are listed (including those with \"Note\"). Isolates categorised as screen positive should be tested for susceptibility to individual agents or reported resistant. | [3] For benzylpenicillin screen negative isolates, susceptibility can be inferred from benzylpenicillin or ampicillin. For benzylpenicillin screen positive isolates, susceptibility is inferred from ampicillin. | [2] The addition of a beta-lactamase inhibitor does not add clinical benefit."
"EUCAST 2023" "human" "human" "DISK" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 15 15 FALSE FALSE "[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2023" "human" "human" "MIC" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)" 2 2 FALSE FALSE "[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 21 21 FALSE FALSE
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "5 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "1.25/23.75 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2023" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
"EUCAST 2023" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2023" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 13.1)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2023" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2023" "human" "human" "MIC" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2023" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4 "IPM" "Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)" "10 mcg" 50 19 FALSE FALSE "[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
@@ -11861,28 +12166,105 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2022" "human" "human" "MIC" "B_STRPT_VIRI" 2.6 "TZP" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)" FALSE FALSE "[No breakpoint] EUCAST gives Note (see note) | [1] Benzylpenicillin (MIC or disk diffusion) can be used to screen for beta-lactam resistance in viridans group streptococci. Isolates categorised as screen negative can be reported susceptible to beta-lactam agents for which clinical breakpoints are listed (including those with \"Note\"). Isolates categorised as screen positive should be tested for susceptibility to individual agents or reported resistant. | [3] For benzylpenicillin screen negative isolates (inhibition zone >=18 mm or MIC <=0.25 mg/L), susceptibility can be inferred from benzylpenicillin or ampicillin. For benzylpenicillin screen positive isolates (inhibition zone <18 mm or MIC >0.25 mg/L), susceptibility is inferred from ampicillin. | [2] The addition of a beta-lactamase inhibitor does not add clinical benefit."
"EUCAST 2022" "human" "human" "DISK" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 15 15 FALSE FALSE "[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2022" "human" "human" "MIC" "B_STRPT_VIRI" 2.5 "VAN" "Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)" 2 2 FALSE FALSE "[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 21 21 FALSE FALSE
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI" 3 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI" 3 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_ALGN" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_ALGN" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_CHLR" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_CHLR" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2.1 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" FALSE FALSE "[No breakpoint] EUCAST gives IE (insufficient evidence)"
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_FLVL" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_FLVL" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_PRHM" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_PRHM" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 16 16 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "AZM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 4 4 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 22 22 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CAZ" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CIP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 21 21 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "CTX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "DOX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "ERY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "15 mcg" 12 12 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 23 23 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "LVX" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.25 0.25 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 24 24 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "MEM" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "PEF-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "5 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "1.25/23.75 mcg" 18 18 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "SXT" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 0.5 0.5 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
"EUCAST 2022" "human" "human" "DISK" "Screen" "B_VIBRI_VLNF" 2 "TCY-S" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30 mcg" 20 20 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
"EUCAST 2022" "human" "human" "DISK" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" "30/6 mcg" 26 26 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
"EUCAST 2022" "human" "human" "MIC" "B_VIBRI_VLNF" 2 "TZP" "Vibrio (file: Clinical Breakpoint Tables v. 12.0)" 1 1 FALSE FALSE "[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2022" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2022" "human" "human" "MIC" "B_[FAM]_MORGNLLC" 4.1 "IMR" "Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)" FALSE FALSE "[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
"EUCAST 2022" "human" "human" "DISK" "B_[FAM]_MORGNLLC" 4 "IPM" "Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)" "10 mcg" 50 19 FALSE FALSE "[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
Binary file not shown.